Santa Cruz Tech Beat


SomaGenics: $2.275M in NIH grants, four patents, and more

Sara Isenberg
Santa Cruz Tech Beat, Publisher

Translating RNA discoveries into innovative products

Santa Cruz Tech Beat published Six Companies to Watch in the Emerging Santa Cruz Biotech Hub almost a year ago (February 27Biotechnology word cloud, 2014).

SomaGenics was one of those companies to watch.

Originally incorporated in 1997 as a technology spin-out from SRI, the company is now located on Delaware Avenue, in Santa Cruz.

Good news to start the new year

Last month, SomaGenics announced several items of good news.

  1. SomaGenics was recently awarded $2,275,000 in Small Business Innovation Research (SBIR) grants from the NIH to further develop and expand its RNA-based technologies in the areas of wound healing, hepatitis delta virus (HDV) therapeutics, microRNA (miRNA) expression profiling, and next-generation sequencing. Read more…
  2. SomaGenics recently had four patents covering various aspects of its small RNA platform technologies issued or allowed by the US and European Patent Offices. Read more…
  3. SomaGenics and collaborators recently published exciting results on the efficacy of RNA interference (RNAi) therapeutics against the hepatitis C virus (HCV) based on the company’s sshRNA™ platform. Read more…

For more information:



Related Posts

Sign up for our free weekly email digest!

  • This field is for validation purposes and should be left unchanged.

Follow Now

Facebook Feed